In a unanimous decision released Thursday, the Supreme Court held that a group challenging the Food and Drug Administration’s release of the abortion drug mifepristone did not have standing to sue. “Under Article III of the Constitution, a plaintiff’s desire to make a drug less available for others does not establish standing to sue,” Justice Brett Kavanaugh wrote. “Nor do the plaintiffs’ other standing theories suffice.” The lawsuit in question came from anti-abortion doctors in Texas who argued the FDA had not done enough to ensure the safety of the drug before it was approved decades ago. W…